NCT07244003 Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control Status RECRUITING Phase PHASE4
NCT07225816 Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected) Status RECRUITING Phase PHASE1
NCT07029009 Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY) Status RECRUITING Phase PHASE2
NCT06818292 Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists Status COMPLETED Phase NA
NCT06501326 Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease Status RECRUITING Phase PHASE4
NCT06283641 Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan. Status COMPLETED Phase N/A
NCT06099067 Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP) Status COMPLETED Phase N/A
NCT05965908 Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome Status COMPLETED Phase PHASE3
NCT05779644 Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus Status UNKNOWN Phase NA
NCT05579249 A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America Status COMPLETED Phase PHASE4
NCT05467514 Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT05438186 INSPIRE Turkey :A Research Study Looking at the Clinical Parameters Associated With Use and Discontinuation of Saxenda® in Local Clinical Practice in Turkey by Analysing Past Patient Medical Records Status WITHDRAWN Phase N/A
NCT05360147 Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT05313529 LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes Status ACTIVE_NOT_RECRUITING Phase NA
NCT05268627 Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss Status UNKNOWN Phase NA
NCT05268237 Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus Status RECRUITING Phase PHASE1/PHASE2